Literature DB >> 2562243

Immunoglobulin VH gene expression in human B cell lines and tumors: biased VH gene expression in chronic lymphocytic leukemia.

T Logtenberg1, M E Schutte, G Inghirami, J E Berman, F H Gmelig-Meyling, R A Insel, D M Knowles, F W Alt.   

Abstract

We have studied frequencies of VH gene utilization in a panel of monoclonal Epstein-Barr virus (EBV)-transformed B cell lines derived from human adult and fetal tissues as well as in monoclonal B cells obtained from fresh chronic lymphocytic leukemia (CLL) samples. The results show that IgM-secreting EBV cell lines from both fetal and adult tissues utilize VH genes from particular families roughly in proportion to estimated family size, suggesting that the repertoire of sigM-positive B cells in both fetal and adult organs is 'normalized' with respect to the V(H) gene family. In contrast, we find a highly biased pattern of VH gene expression in CLLs. The significance of these findings is discussed in the context of mechanisms that could be involved in normal B cell repertoire development and in the process of malignant transformation of precursors of CLL.

Entities:  

Mesh:

Year:  1989        PMID: 2562243     DOI: 10.1093/intimm/1.4.362

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  17 in total

1.  Preferential utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life.

Authors:  H W Schroeder; J Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 2.  Properties of polyreactive natural antibodies to self and foreign antigens.

Authors:  T Logtenberg
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

3.  A deletion map of the human immunoglobulin heavy chain variable region.

Authors:  M A Walter; H M Dosch; D W Cox
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

4.  Analysis of human VH gene repertoire expression in peripheral CD19+ B cells.

Authors:  C Demaison; D David; F Letourneur; J Thèze; S Saragosti; M Zouali
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium.

Authors:  B E Clausen; S L Bridges; J C Lavelle; P G Fowler; S Gay; W J Koopman; H W Schroeder
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

6.  Human B cells accumulate immunoglobulin V gene somatic mutations in a cell contact-dependent manner in cultures supported by activated T cells but not in cultures supported by CD40 ligand.

Authors:  S C Huang; A M Glas; G V Pinchuk; E H Van Montfort; S P Rao; R Jiang; E C Milner
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

7.  Restricted use of fetal VH3 immunoglobulin genes by unselected B cells in the adult. Predominance of 56p1-like VH genes in common variable immunodeficiency.

Authors:  J Braun; L Berberian; L King; I Sanz; H L Govan
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

8.  Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient.

Authors:  N Harindranath; I S Goldfarb; H Ikematsu; S E Burastero; R L Wilder; A L Notkins; P Casali
Journal:  Int Immunol       Date:  1991-09       Impact factor: 4.823

9.  Consensus primers for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell lymphomas.

Authors:  M Uchiyama; C Maesawa; A Yashima; T Itabashi; Y Ishida; T Masuda; T Maesawa
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

10.  Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells.

Authors:  X Mariette; Y Levy; M L Dubreuil; L Intrator; F Danon; J C Brouet
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.